Journal
CHEMICAL SOCIETY REVIEWS
Volume 50, Issue 7, Pages 4245-4258Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/d0cs01386b
Keywords
-
Categories
Funding
- Engineering and Physical Sciences Research Council
- Royal Society (Wolfson Research Merit Award)
Ask authors/readers for more resources
RiPPs are recognized as a potential source of antimicrobial drugs due to their potent activity and high stability, but issues such as low solubility and poor bioavailability often hinder their clinical development. Chemical synthesis can help overcome some of these challenges, and the structural complexity of RiPPs makes them interesting synthetic targets.
The growing antimicrobial resistance crisis necessitates the discovery and development of novel classes of antibiotics if a 'postantibiotic era' is to be avoided. Ribosomally synthesised and post-translationally modified peptides, or RiPPs, are becoming increasingly recognised as a potential source of antimicrobial drugs. This is due to a combination of their potent antimicrobial activity and their high stability relative to unmodified linear peptides. However, as peptide drugs, their clinical development is often perturbed by issues such as low solubility and poor bioavailability. Chemical synthesis has the potential to overcome some of these challenges. Furthermore, the structural complexity of RiPPs makes them interesting synthetic targets in their own right, with the total synthesis of some structural classes having only been recently realised. This review focusses on the use of RiPPs as antimicrobial agents and will highlight various strategies that have been employed to chemically synthesise three major classes of RiPPs: lasso peptides, cyclotides, and lanthipeptides.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available